Substance-Exposed Pregnancies: What to Know As They Grow


Sponsor: Opioid Response Network in collaboration with the American Psychiatric Nurses Association

This presentation will explore how substance use during pregnancy impacts the maternal/fetal development and increases the neurological vulnerabilities of the neonate.  The unique challenges and opportunities of providing care to a substance-exposed pregnancy will be explored.  The importance of screening procedures will be discussed and how the information obtained during the screening influences the treatment plan.

 Kathleen Schachman, PhD, PMHNP-BC, FAANP, FIAAN

For more information and to register click here

Learning Outcomes:
Upon completion of this presentation, the participant will be able to: 

  • Describe two ways that substance use during pregnancy impacts maternal/fetal developmental and neurological vulnerabilities of the neonate.
  • Identify the unique challenges and opportunities in providing care for substance-exposed pregnancies.
  • Implement screening procedures identify high-risk or problematic substance use during pregnancy.
  • Plan treatment approaches to optimize maternal and neonatal outcomes.

This is an open ended event